Asthma and Allergy Associates

What Asthma and Allergy Associates does

Asthma and Allergy Associates, operating commercially as AllerVie Health, is a private, multi-site clinical provider specializing in the diagnosis and treatment of allergic and respiratory conditions. The company delivers services through a network of physical clinics operating under multiple brand names including AllerVie Health, Armitage Allergy, and Allergy & Asthma Associates of DuPage. Its service portfolio spans diagnostic procedures (skin allergy testing, blood testing, allergy patch testing, pulmonary function tests) and treatment modalities including allergen immunotherapy, biologic therapy for severe asthma, and structured food allergy treatment programs. The company also maintains AllerVie Clinical Research, an affiliated research entity that conducts adult and pediatric clinical studies in asthma, allergy, and immunology.

The company serves individual patients across the United States, with disclosed clinic locations concentrated in Illinois (Chicago/Lincoln Park, Downers Grove, and Naperville) alongside a corporate headquarters in Frisco, Texas. Its go-to-market motion is primarily direct-to-consumer, supplemented by a 'Refer a Patient' channel and a 'Become a Partner' program indicating formal physician-to-physician referral and partnership pathways. Revenue is generated through per-visit and per-procedure clinical billing, with services covered by accepted insurance plans and patient payments facilitated through a third-party patient portal.

The business is positioned as a scaled specialty-care roll-up operating under a unified AllerVie master brand while retaining legacy brand identities in acquired markets. Its product surface is purely clinical, with no software platforms, mobile applications, or proprietary technology products disclosed. Competitive differentiation is framed around geographic accessibility, breadth of service offering, and affiliation with a research operation that gives patients access to emerging therapies and gives the platform a credentialed identity with referring physicians.

Name

Asthma and Allergy Associates

Legal name

AllerVie Health

Website

https://allergistsdupage.com

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Asthma and Allergy Associates, operating as AllerVie Health, is a private multi-site clinical provider delivering allergy and asthma diagnosis, immunotherapy, and biologic therapy through a nationwide network of clinics serving individual patients across the United States.

Ownership category

akta.pro rank

Product category

Allergy and Asthma Clinical Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL), Food Allergy Evaluation & Management (HLAKAAAD), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Allergy treatment services
• Asthma clinical care
• Allergen immunotherapy
• Allergy diagnostic testing
• Pulmonary function testing

Headquarters

HQ city

Naperville

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Clinical Healthcare Services: Revenue generated from patient visits, diagnostic testing, and treatment procedures including allergy shots, immunotherapy, and biologic therapies. Services are billed per visit or procedure, with many covered by accepted insurance plans.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Asthma and Allergy Associates operates as part of the AllerVie Health network of allergy and asthma clinics, providing diagnostic testing (skin, blood, and patch allergy testing) and treatment services including allergen immunotherapy (allergy shots), biologic therapy for severe asthma, pulmonary function testing, and food allergy treatment programs. Services are delivered in person through clinical locations staffed by physicians, nurse practitioners, and physician assistants, with an affiliated clinical research operation supporting new therapy development.

Product overview

AllerVie Health is a nationwide allergy and asthma clinic network offering a unified healthcare service platform. The company provides comprehensive diagnostic testing services (Allergy Patch Testing, Skin Allergy Testing, Blood Testing for Allergies) and treatment programs (Allergy Shots, Immunotherapy, Biologic Therapy for Asthma, Food Allergy Treatment Program, Pulmonary Function Tests). The portfolio centers on allergy and asthma condition management across conditions including Allergic Rhinitis, Food Allergies, Asthma (Adult-Onset, Childhood, Exercise-Induced, Severe), Hives, and Hereditary Angioedema. The services are delivered through clinical locations with affiliated clinical research operations.

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• AllerVie Clinical ResearchcoreOthersAllerVie Clinical Research is an affiliate organization that conducts clinical studies in adult and pediatric patients. The affiliate contributes to the advancement of new therapies for asthma, allergies, and other related immunological conditions.

Scale indicators2 records

Expansion highlights5 records

Direct peers

• Allergy Partners: Largest U.S. allergy, asthma, and immunology physician group network with clinics across multiple states. Directly comparable to AllerVie as a multi-site specialty allergy platform pursuing the same consolidation and integrated care model.
• Family Allergy & Asthma: Multi-state allergy and asthma practice network offering diagnostic testing, immunotherapy, and biologic therapy. Closely mirrors AllerVie's service portfolio and multi-clinic operating model.
• ENT and Allergy Associates: Large New York-metro physician group providing allergy services alongside broader ENT offerings. Comparable to AllerVie as a multi-site specialty practice with shared diagnostics and immunotherapy service lines.

Regional players

• Atlanta Allergy & Asthma: Long-standing allergy and asthma practice concentrated in the Southeast U.S. Comparable to AllerVie in clinical service offering and patient mix, but operates primarily in a different geography.
• Premier Allergy & Asthma: Ohio-based allergy and asthma practice network offering testing, immunotherapy, and biologic treatment. Comparable service scope to AllerVie but with regional Midwest concentration rather than national reach.
• Colorado Allergy & Asthma Centers, P.C. Multi-location allergy and asthma practice in the Denver/mountain region offering diagnostic testing and immunotherapy. Comparable specialty practice model to AllerVie but with a distinct geographic footprint.

Others

• Allergy & Asthma Network: Patient advocacy and education nonprofit focused on allergy and asthma conditions. Not a direct competitor, but an ecosystem participant shaping patient awareness and referral flow relevant to AllerVie's patient acquisition strategy.
• Asthma and Allergy Foundation of America (AAFA): National patient advocacy organization for asthma and allergic diseases. Relevant ecosystem participant influencing patient awareness, certification programs (e.g., asthma-friendly products), and policy that affect AllerVie's market.

Emerging players

• United Allergy Services: Allergy testing and immunotherapy services company that partners with primary care practices to deliver allergy care in non-specialty settings. Adjacent comparator to AllerVie as it targets the same patient demand via a different delivery model.

Broad incumbents

• Sanofi US: Manufacturer of Dupixent (dupilumab), a leading biologic for severe asthma and related atopic conditions, and other respiratory/allergy therapeutics. Comparable to AllerVie only in that it serves the same severe-asthma biologic therapy channel, but operates as a pharmaceutical manufacturer rather than a clinical care provider.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• YouTubeyoutube.com/@allerviehealth744
• Facebookfacebook.com/AllerVieHealth
• LinkedInlinkedin.com/company/allergy-and-asthma-associates-of-dupage-p.c.
• Instagraminstagram.com/allerviehealth

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asthma and Allergy Associates